Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Krum

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Circulation|September 15, 1995
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failureH Krum, J D Sackner-Bernstein, R L Goldsmith, et al.
Journal of Human Hypertension|September 9, 2016
Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervationN Eikelis, D Hering, P Marusic, et al.
Internal Medicine Journal|August 23, 2012
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classesD J Campbell, M McGrady, D L Prior, et al.
The Medical Journal of Australia|November 18, 1991
Cardiac risk factor management. Experience of an outpatient hypertension clinicN E Straznicky, L G Howes, H Krum, et al.
Cardiovascular Research|August 25, 2007
Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 ratK A Connelly, D J Kelly, Y Zhang, et al.
The New England Journal of Medicine|June 2, 2001
Effect of carvedilol on survival in severe chronic heart failureM Packer, A J Coats, M B Fowler, et al.
Heart, Lung & Circulation|February 14, 2006
The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology projectA E Ajani, G Szto, S J Duffy, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Circulation|September 15, 1995
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failureH Krum, J D Sackner-Bernstein, R L Goldsmith, et al.
Journal of Human Hypertension|September 9, 2016
Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervationN Eikelis, D Hering, P Marusic, et al.
Internal Medicine Journal|August 23, 2012
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classesD J Campbell, M McGrady, D L Prior, et al.
The Medical Journal of Australia|November 18, 1991
Cardiac risk factor management. Experience of an outpatient hypertension clinicN E Straznicky, L G Howes, H Krum, et al.
Cardiovascular Research|August 25, 2007
Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 ratK A Connelly, D J Kelly, Y Zhang, et al.
The New England Journal of Medicine|June 2, 2001
Effect of carvedilol on survival in severe chronic heart failureM Packer, A J Coats, M B Fowler, et al.
Heart, Lung & Circulation|February 14, 2006
The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology projectA E Ajani, G Szto, S J Duffy, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 12